Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphatic Malformation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00874172
What this trial is testing

Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy

Who this might be right for
Sickle Cell Anemia
Assistance Publique - Hôpitaux de Paris 176
Post-approval studies (Phase 4)Study completedNCT00707850
What this trial is testing

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

Who this might be right for
Hepatitis CThalassemia
Baqiyatallah Medical Sciences University 300
Large-scale testing (Phase 3)Study completedNCT03974113
What this trial is testing

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 32
Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Not applicableLooking for participantsNCT06546137
What this trial is testing

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Who this might be right for
Cardiomyopathy, HypertrophicCardiomyopathy, DilatedCardiomyopathy Restrictive+11 more
Hospital do Coracao 1,211
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT04334057
What this trial is testing

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 23
Not applicableStudy completedNCT06904612
What this trial is testing

Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels

Who this might be right for
Neural Tube DefectsFolic Acid DeficiencySpina Bifida+4 more
Hydrocephalus and Neuroscience Institute 200
Not applicableStudy completedNCT00005467
What this trial is testing

Indices of Severity and Prognosis for Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellBlood Disease
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableLooking for participantsNCT07404644
What this trial is testing

An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

Who this might be right for
Von Willebrand Disease (vWD)
Takeda 13
Not applicableEnded earlyNCT02636387
What this trial is testing

Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

Who this might be right for
Nocturnal EnuresisAnemia, Sickle Cell
Montefiore Medical Center 14
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Not applicableLooking for participantsNCT06923111
What this trial is testing

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]

Who this might be right for
Sickle Cell Disease
Nova Laboratories Limited 180
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableNot Yet RecruitingNCT07502781
What this trial is testing

Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants

Who this might be right for
Extremely Premature InfantAnemia NeonatalBlood Transfusion+6 more
Hospital Clinic of Barcelona 176
Not applicableActive Not RecruitingNCT07560007
What this trial is testing

The Bleeding Assessment Tool (BAT)

Who this might be right for
Bleeding DisorderVon Willebrand Disease (VWD)
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)Study completedNCT00052299
What this trial is testing

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 472
Post-approval studies (Phase 4)Study completedNCT00357656
What this trial is testing

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Who this might be right for
Hemophilia A
Baxalta now part of Shire 85
Next Page